Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06287203 · ClinicalTrials.gov registry record · NA
Novel Prevention Intervention Program to Reduce Risky Patterns of Substance Use Among Emerging Adults
A NA study of Substance Use, sponsored by Rutgers, The State University of New Jersey.
- Active
- Registry status
- NA
- Development phase
- 660
- Enrollment target
- 1
- Study location
NCT06287203: Active NA study of Substance Use, sponsored by Rutgers, The State University of New Jersey.
NCT06287203 is a NA study of Substance Use that is active but no longer recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 660 participants, below the 1,253-participant average among 88 other Substance Use trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06287203, a NA study of Substance Use, is active but no longer recruiting, sponsored by Rutgers, The State University of New Jersey.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 660 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test whether completion of a new personalized feedback program is associated with reductions in risky substance use among emerging adults (18-25 years of age).
Primary Outcome
Alcohol consumption will be measured using the Alcohol Use Disorders Identification Test (AUDIT) consumption subscale. The AUDIT-C consists of 3 items (e.g., "how often do you have a drink containing alcohol"). Items are rated on a 5-point scale. Items will be summed to create subscale totals with higher scores representing higher levels of that behavior (e.g., higher alcohol consumption. Scores can range from 0 to 12.
Conditions Studied
Interventions
- BEHAVIORAL Addiction Risk Feedback Program
Study Locations (1)
New Jersey
- Rutgers Robert Wood Johnson Medical School - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 660 participants |
| Start Date | 2024-04-12 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What the registry record for NCT06287203 still lists
NCT06287203 is an interventional study that assigns participants to a tested intervention. The registered 660 participants enrollment target is mid-sized for trials with a published cap, below the 1,253-participant average among 88 other Substance Use trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which Addiction Risk Feedback Program is the first listed.
NCT06287203 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06287203 about?
NCT06287203 is a clinical study titled "Novel Prevention Intervention Program to Reduce Risky Patterns of Substance Use Among Emerging Adults". The purpose of this research study is to test whether completion of a new personalized feedback program is associated with reductions in risky substance use among emerging adults (18-25 years of age).
What is the current status of trial NCT06287203?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 660 participants. The study started on 2024-04-12. Estimated completion is 2026-01-31.
What conditions does trial NCT06287203 study?
This clinical trial studies the following conditions: Substance Use.
What interventions are being tested in trial NCT06287203?
The interventions under investigation include: Addiction Risk Feedback Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06287203?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06287203 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06287203's enrollment target sits among peer trials
660 12th of 88 higher than 77 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
- NCT03346694 · 660 participants · NA
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
- NCT05407636 · 660 participants · Phase 3
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
- NCT05470205 · 660 participants · Phase 3
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI